Prostate Cancer Misdiagnosis

According to The Prostate Cancer Foundation, prostate cancer is the most common non-skin cancer in the United States. It affects one in six men and in 2014, according to the foundation’s projections, more than 233,000 men will be diagnosed with prostate cancer. Also, more than 2.5 million Americans are currently living with prostate cancer and over 29,000 will die from it this year. There are a wide variety of treatments for prostate cancer and all of them are more effective when accompanied by early detection of the disease.

Prostate cancer misdiagnosis is common and some patients unfortunately do not get the benefit of more effective treatment because their cancer is not diagnosed in a timely manner.

It is possible to detect prostate cancer in its earliest stages. This can be done with various tests, including but not limited to prostate-specific antigen (PSA) blood testing, digital rectal exams, biopsies, etc. It is particularly important to run tests and take cognizance of the significance of a patient’s clinical presentation, including when the patient is exhibiting symptoms such as frequent and/or burning urination, sexual dysfunction, and pain in the back, hips, and upper thighs.

Failure to accurately and timely detect, diagnose, and treat cancer is a form of medical malpractice that can have significant consequences for patients.

If you believe you have suffered as a result of cancer misdiagnosis or untimely diagnosis, it is important that you contact a New Jersey law firm that has extensive experience handling medical malpractice cases relating to cancer misdiagnosis. A knowledgeable medical malpractice lawyer at Blume Forte will help you to protect your rights and assist you in pursuing compensation for your significant losses.

Related Articles: